Literature DB >> 23708562

Memory CD4 T cell-mediated immunity against influenza A virus: more than a little helpful.

K Kai McKinstry1, Richard W Dutton, Susan L Swain, Tara M Strutt.   

Abstract

Recent observations have uncovered multiple pathways whereby CD4 T cells can contribute to protective immune responses against microbial threats. Incorporating the generation of memory CD4 T cells into vaccine strategies thus presents an attractive approach toward improving immunity against several important human pathogens, especially those against which antibody responses alone are inadequate to confer long-term immunity. Here, we review how memory CD4 T cells provide protection against influenza viruses. We discuss the complexities of protective memory CD4 T cell responses observed in animal models and the potential challenges of translating these observations into the clinic. Specifically, we concentrate on how better understanding of organ-specific heterogeneity of responding cells and defining multiple correlates of protection might improve vaccine-generated memory CD4 T cells to better protect against seasonal, and more importantly, pandemic influenza.

Entities:  

Mesh:

Year:  2013        PMID: 23708562      PMCID: PMC3874125          DOI: 10.1007/s00005-013-0236-z

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  112 in total

1.  Functional responses and costimulator dependence of memory CD4+ T cells.

Authors:  C A London; M P Lodge; A K Abbas
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

2.  Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children.

Authors:  Steven Black; Uwe Nicolay; Timo Vesikari; Markus Knuf; Giuseppe Del Giudice; Giovanni Della Cioppa; Theodore Tsai; Ralf Clemens; Rino Rappuoli
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

3.  Annual influenza vaccination affects the development of heterosubtypic immunity.

Authors:  Rogier Bodewes; Pieter L A Fraaij; Joost H C M Kreijtz; Martina M Geelhoed-Mieras; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  Vaccine       Date:  2012-05-27       Impact factor: 3.641

4.  Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels.

Authors:  Grazia Galli; Duccio Medini; Erica Borgogni; Luisanna Zedda; Monia Bardelli; Carmine Malzone; Sandra Nuti; Simona Tavarini; Chiara Sammicheli; Anne K Hilbert; Volker Brauer; Angelika Banzhoff; Rino Rappuoli; Giuseppe Del Giudice; Flora Castellino
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

Review 5.  Similarities and differences in CD4+ and CD8+ effector and memory T cell generation.

Authors:  Robert A Seder; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-09       Impact factor: 25.606

6.  CD4 T cell-independent antibody response promotes resolution of primary influenza infection and helps to prevent reinfection.

Authors:  Byung O Lee; Javier Rangel-Moreno; Juan E Moyron-Quiroz; Louise Hartson; Melissa Makris; Frank Sprague; Frances E Lund; Troy D Randall
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

7.  Physiological numbers of CD4+ T cells generate weak recall responses following influenza virus challenge.

Authors:  Paul G Thomas; Scott A Brown; Melissa Y Morris; Wen Yue; Jenny So; Cory Reynolds; Richard J Webby; Peter C Doherty
Journal:  J Immunol       Date:  2010-01-08       Impact factor: 5.422

8.  Increased membrane cholesterol in lymphocytes diverts T-cells toward an inflammatory response.

Authors:  Jacqueline Surls; Cristina Nazarov-Stoica; Margaret Kehl; Cara Olsen; Sofia Casares; Teodor-D Brumeanu
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

9.  Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets.

Authors:  Amorsolo L Suguitan; Josephine McAuliffe; Kimberly L Mills; Hong Jin; Greg Duke; Bin Lu; Catherine J Luke; Brian Murphy; David E Swayne; George Kemble; Kanta Subbarao
Journal:  PLoS Med       Date:  2006-09       Impact factor: 11.069

10.  Functional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin.

Authors:  P A Scherle; W Gerhard
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more
  18 in total

1.  M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection.

Authors:  D G Eliasson; A Omokanye; K Schön; U A Wenzel; V Bernasconi; M Bemark; A Kolpe; K El Bakkouri; T Ysenbaert; L Deng; W Fiers; X Saelens; N Lycke
Journal:  Mucosal Immunol       Date:  2017-03-01       Impact factor: 7.313

Review 2.  Early programming and late-acting checkpoints governing the development of CD4 T-cell memory.

Authors:  Kunal Dhume; Karl Kai McKinstry
Journal:  Immunology       Date:  2018-05-21       Impact factor: 7.397

3.  Direct IL-6 Signals Maximize Protective Secondary CD4 T Cell Responses against Influenza.

Authors:  Tara M Strutt; Karl Kai McKinstry; Yi Kuang; Caroline M Finn; Ji Hae Hwang; Kunal Dhume; Stewart Sell; Susan L Swain
Journal:  J Immunol       Date:  2016-09-19       Impact factor: 5.422

4.  CD4 T cell help is limiting and selective during the primary B cell response to influenza virus infection.

Authors:  Shabnam Alam; Zackery A G Knowlden; Mark Y Sangster; Andrea J Sant
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

Review 5.  CD4 T-cell memory generation and maintenance.

Authors:  David J Gasper; Melba Marie Tejera; M Suresh
Journal:  Crit Rev Immunol       Date:  2014       Impact factor: 2.214

6.  Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children.

Authors:  Kristin G-I Mohn; Geir Bredholt; Karl A Brokstad; Rishi D Pathirana; Hans J Aarstad; Camilla Tøndel; Rebecca J Cox
Journal:  J Infect Dis       Date:  2014-11-25       Impact factor: 5.226

7.  Intranasal delivery of influenza rNP adjuvanted with c-di-AMP induces strong humoral and cellular immune responses and provides protection against virus challenge.

Authors:  Maria Victoria Sanchez; Thomas Ebensen; Kai Schulze; Diego Cargnelutti; Paulina Blazejewska; Eduardo A Scodeller; Carlos A Guzmán
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

Review 8.  The Differentiation and Protective Function of Cytolytic CD4 T Cells in Influenza Infection.

Authors:  Deborah M Brown; Anna T Lampe; Aspen M Workman
Journal:  Front Immunol       Date:  2016-03-09       Impact factor: 7.561

Review 9.  Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection?

Authors:  Jennifer A Juno; David van Bockel; Stephen J Kent; Anthony D Kelleher; John J Zaunders; C Mee Ling Munier
Journal:  Front Immunol       Date:  2017-01-23       Impact factor: 7.561

10.  Humoral and cell-mediated immune responses to H5N1 plant-made virus-like particle vaccine are differentially impacted by alum and GLA-SE adjuvants in a Phase 2 clinical trial.

Authors:  Stéphane Pillet; Éric Aubin; Sonia Trépanier; Jean-François Poulin; Bader Yassine-Diab; Jan Ter Meulen; Brian J Ward; Nathalie Landry
Journal:  NPJ Vaccines       Date:  2018-01-23       Impact factor: 7.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.